Home

Welcome

Scottish Strategic Network for Genomic Medicine

Welcome to the online home for the Scottish Strategic Network for Genomic Medicine (SSNGM). You can find updates on developments and news about the network here. View some of the key pieces of work for the SSNGM linked below or explore the entire site using the navigation menu at the top of the page. If you have any feedback, we would love to hear it. You can get in touch via the details on our contact us page.

Network Updates

SSNGM Horizon Scanning

The Horizon Scanning for new genomic tests, technologies, and innovations is an important development for the SSNGM.

Horizon scanning is guided by a collaborative process which is managed through a shared spreadsheets led by genomic laboratory experts. If you’re aware of emerging genomic tests or developments please share them via our submission form. Your input supports strategic forward planning and innovation.

< Scan the QR code or follow the link here.

The Scottish Genomics Test Advisory Groups (SG-TAG) were established to support the evaluation of new or changes to genomic tests for cancer and rare and inherited disease required for implementation into NHS Scotland. 

In September 2024, the Scottish Strategic Network for Genomic Medicine (SSNGM) Steering Group approved an interim change to the SG-TAG process due to the existing financial constraints on NHS services in Scotland. 

A new interim process has been established and will be implemented from Monday the 14th October 2024. This new process will streamline the submission for gathering the requirements for new or changes genomic tests for patients in Scotland.  New submissions will be regularly reviewed by the SSNGM horizon scanning group for consideration of next steps, but a full SG-TAG evaluation will not take place at this time.   

The SSNGM is committed to working with our Scottish Government genomics policy and our National Services Directorate (NSD) commissioning colleagues to identify new sources of funding for genomic tests.  We will communicate further updates regarding this and SG-TAG in due course. 

In the meantime, we would like to thank all our colleagues across Scotland for their work and on-going support for SG-TAG and the SSNGM. If you would like to submit a request for a new genomic test using the new interim process, please contact our network team on NSS.genomicsnetwork@nhs.scot to obtain the appropriate form.

Thank you for your understanding and patience during this time.
Direct-to-consumer (DTC) tests are genetic or genomic testing kits offered by commercial companies directly to customers. Many companies claim to inform people about disease risks and the advertising will often present DTC genetic testing as empowering, and the testing process offered is easy and simple (saliva DNA kits sent through the post).
 
We fully support individual efforts to be more health aware and to adopt a healthier lifestyle. DTC tests can also increase awareness of genetics and its influence on health. There are, however, potential problems with DTC tests and some important considerations that consumers, and healthcare professionals, need to know about.
 
If you have bought a DTC test or are considering one:

When it comes to DTC genetic tests, it is important that you know exactly what the test you are buying involves. Some DTC tests look at SNPs or genetic alterations associated with an increased risk of certain cancers. These results could have significant implications for your or other members of your family. However, there have been several cases where these results have been wrong. Your DTC test result could cause a lot of undue worry in these circumstances. Similarly, having a ‘normal’ result, does not mean you are not at increased risk of certain cancers. This is because these tests aren’t specifically looking at the relevant parts of the genetic code for this information.
 
If you are concerned about your family history of disease (including cancer), or feel you might have a genetic condition, please discuss this with your GP who can refer you to a clinical genetics service if appropriate. DTC genetic tests are not designed to diagnose a medical condition and should not be used as a substitute for visiting your doctor if you are at all concerned about your current health or your risk of developing a condition in the future. It is also important to know that DTC tests are not designed for use on children.
 
If you do choose to have a DTC genetic test, you should make sure that you understand what the company will do with your data. Some companies might store, sell or conduct research on your genetic data.
 
You should also be aware that NHS Scotland healthcare professionals and scientists cannot interpret any raw data or results obtained from a DTC genetic test.
 
More information can be found on the Genetic Alliance website and the Association of Genetic Nurses and Counsellors website.
 
If you are a healthcare professional:
 
A position statement developed by the Royal College of General Practitioners (RCGP) and the British Society for Genetic Medicine (BSGM) recommended caution when asked to offer, or provide, clinical expertise about the results of DTC genomic or genetic testing.
 
This is because the analytical validity, sensitivity and clinical utility of such testing may be much lower than is popularly perceived. For certain types of DTC results, there is a very high chance of false positive or false negative results. This means that patients should be offered the NHS care which would otherwise have been offered (e.g. family history and risk assessment, healthy lifestyle advice, or referral to specialist care) regardless of their DTC result.

Scottish Genomic Test Directories Version 5!

Click here to view the latest version of the Scottish Genomic Test Directories for Cancer and Rare and Inherited Disease. The SSNGM and the genomics centres are working closely to develop an online version of the test directory for better navigation and searchability. This is part of a wider transformation project to digitise the Scottish Genomic Test Directories to form the basis for wider applications.

Webinar Series

The Scottish Strategic Network for Genomic Medicine (SSNGM) and the Scottish Pathology Network (SPAN) will deliver a series of educational sessions for pathology and genomic laboratories, followed by specific subject area webinars. Click here to view previous and upcoming sessions.
Don’t miss this opportunity to expand your expertise and stay informed on the latest developments in genomics and pathology!